COMP did not significantly affect ovarian cancer cell proliferation in vitro, as also observed with breast and prostate cancer cells [9, 11], consistent with no observed correlation between COMP in cancer cells and Ki67 by immunochemistry analysis. This evidence concerns the gene COMP and ovarian carcinoma.